Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

BACKGROUND: Large outbreaks of Lassa fever (LF) occur annually in Nigeria. The case fatality rate among hospitalised cases is ~ 20%. The antiviral drug ribavirin along with supportive care and rehydration are the recommended treatments but must be administered early (within 6 days of symptom onset)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Nastassya L., Bolt, Hikaru, Dan-Nwafor, Chioma, Ipadeola, Oladipupo, Ilori, Elsie, Namara, Geoffrey, Olayinka, Adebola T., Ukponu, Winifred, Iniobong, Akanimo, Amedu, Michael, Akano, Adejoke, Akabike, Kachikwulu O., Okhuarobo, Uwaifiokun, Fagbemi, Stephen, Sampson, Emeka, Newitt, Sophie, Verlander, Neville Q., Bausch, Daniel G., le Polain de Waroux, Olivier, Ihekweazu, Chikwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863257/
https://www.ncbi.nlm.nih.gov/pubmed/33541278
http://dx.doi.org/10.1186/s12879-021-05822-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863257/
https://www.ncbi.nlm.nih.gov/pubmed/33541278
http://dx.doi.org/10.1186/s12879-021-05822-4

Ejemplares similares